Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 535

1.

Usefulness of Attenuation Imaging with an Ultrasound Scanner for the Evaluation of Hepatic Steatosis.

Tada T, Iijima H, Kobayashi N, Yoshida M, Nishimura T, Kumada T, Kondo R, Yano H, Kage M, Nakano C, Aoki T, Aizawa N, Ikeda N, Takashima T, Yuri Y, Ishii N, Hasegawa K, Takata R, Yoh K, Sakai Y, Nishikawa H, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Ultrasound Med Biol. 2019 Jul 3. pii: S0301-5629(19)30243-1. doi: 10.1016/j.ultrasmedbio.2019.05.033. [Epub ahead of print]

PMID:
31277922
2.

Eltrombopag enables initiation and completion of pegylated interferon/ribavirin therapy in Japanese HCV-infected patients with chronic liver disease and thrombocytopenia.

Kawaguchi T, Komori A, Fujisaki K, Nishiguchi S, Kato M, Takagi H, Tanaka Y, Notsumata K, Mita E, Nomura H, Shibatoge M, Takaguchi K, Hattori T, Sata M, Koike K.

Exp Ther Med. 2019 Jul;18(1):596-604. doi: 10.3892/etm.2019.7616. Epub 2019 May 24.

3.

Hypozincemia is associated with human hepatocarcinogenesis in hepatitis C virus-related liver cirrhosis.

Shigefuku R, Iwasa M, Katayama K, Eguchi A, Kawaguchi T, Shiraishi K, Ito T, Suzuki K, Koreeda C, Ohtake T, Tokumoto Y, Endo R, Kawamura N, Shiraki M, Habu D, Sakai H, Kato A, Nishiguchi S, Moriwaki H, Suzuki K, Takei Y.

Hepatol Res. 2019 Jun 25. doi: 10.1111/hepr.13388. [Epub ahead of print]

PMID:
31240767
4.

Elevated levels of circulating ITIH4 are associated with hepatocellular carcinoma with nonalcoholic fatty liver disease: from pig model to human study.

Nakamura N, Hatano E, Iguchi K, Sato M, Kawaguchi H, Ohtsu I, Sakurai T, Aizawa N, Iijima H, Nishiguchi S, Tomono T, Okuda Y, Wada S, Seo S, Taura K, Uemoto S, Ikegawa M.

BMC Cancer. 2019 Jun 25;19(1):621. doi: 10.1186/s12885-019-5825-8.

5.

Combined Albumin-Bilirubin Grade and Skeletal Muscle Mass as a Predictor in Liver Cirrhosis.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Jun 1;8(6). pii: E782. doi: 10.3390/jcm8060782.

6.

Association between Sarcopenia and Depression in Patients with Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 May 8;8(5). pii: E634. doi: 10.3390/jcm8050634.

7.

Role of the putative PKC phosphorylation sites of the type IIc sodium-dependent phosphate transporter in parathyroid hormone regulation.

Fujii T, Segawa H, Hanazaki A, Nishiguchi S, Minoshima S, Ohi A, Tominaga R, Sasaki S, Tanifuji K, Koike M, Arima Y, Shiozaki Y, Kaneko I, Ito M, Tatsumi S, Miyamoto KI.

Clin Exp Nephrol. 2019 Jul;23(7):898-907. doi: 10.1007/s10157-019-01725-6. Epub 2019 Mar 21.

PMID:
30895530
8.

Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseases.

Nishimura T, Iijima H, Nishikawa H, Kondo R, Yano H, Kage M, Aoki T, Nakano C, Yuri Y, Ishii N, Hasegawa K, Takata R, Yoh K, Sakai Y, Takashima T, Aizawa N, Ikeda N, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Hepatol Res. 2019 Mar 18. doi: 10.1111/hepr.13332. [Epub ahead of print]

PMID:
30884015
9.

End-of-life care conferences in Japanese nursing homes.

Nishiguchi S, Sugaya N, Inamori M.

Drug Discov Ther. 2019;13(1):47-51. doi: 10.5582/ddt.2019.01002.

10.

Serum Zinc Concentration and Sarcopenia: A Close Linkage in Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2019 Mar 11;8(3). pii: E336. doi: 10.3390/jcm8030336.

11.

Comparison of liver stiffness assessment by transient elastography and shear wave elastography using six ultrasound devices.

Iijima H, Tada T, Kumada T, Kobayashi N, Yoshida M, Aoki T, Nishimura T, Nakano C, Ishii A, Takashima T, Sakai Y, Aizawa N, Nishikawa H, Ikeda N, Iwata Y, Enomoto H, Ide YH, Hirota S, Fujimoto J, Nishiguchi S.

Hepatol Res. 2019 Jun;49(6):676-686. doi: 10.1111/hepr.13319. Epub 2019 Mar 5.

PMID:
30680865
12.

Association of the Body Mass Index with the Presence of Gastroesophageal Varices in Compensated Cirrhotic Patients with Hepatitis C Viral Infection.

Enomoto H, Aizawa N, Ikeda N, Sakai Y, Takata R, Hasegawa K, Miyamoto Y, Inoue M, Nishimura T, Nakano C, Ishii N, Yuri Y, Yoh K, Ishii A, Takashima T, Nishikawa H, Iwata Y, Iijima H, Nishiguchi S.

Ann Clin Lab Sci. 2018 Nov;48(6):801-804.

PMID:
30610054
13.

Effect of Sarcopenia on Sleep Disturbance in Patients with Chronic Liver Diseases.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2018 Dec 22;8(1). pii: E16. doi: 10.3390/jcm8010016.

14.

Health-Related Quality of Life in Chronic Liver Diseases: A Strong Impact of Hand Grip Strength.

Nishikawa H, Enomoto H, Yoh K, Iwata Y, Sakai Y, Kishino K, Ikeda N, Takashima T, Aizawa N, Takata R, Hasegawa K, Ishii N, Yuri Y, Nishimura T, Iijima H, Nishiguchi S.

J Clin Med. 2018 Dec 15;7(12). pii: E553. doi: 10.3390/jcm7120553.

15.

Caffeine-stimulated muscle IL-6 mediates alleviation of non-alcoholic fatty liver disease.

Fang C, Cai X, Hayashi S, Hao S, Sakiyama H, Wang X, Yang Q, Akira S, Nishiguchi S, Fujiwara N, Tsutsui H, Sheng J.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Mar;1864(3):271-280. doi: 10.1016/j.bbalip.2018.12.003. Epub 2018 Dec 12.

PMID:
30553055
16.

Neural Correlates of Working Memory Maintenance in Advanced Aging: Evidence From fMRI.

Suzuki M, Kawagoe T, Nishiguchi S, Abe N, Otsuka Y, Nakai R, Asano K, Yamada M, Yoshikawa S, Sekiyama K.

Front Aging Neurosci. 2018 Nov 6;10:358. doi: 10.3389/fnagi.2018.00358. eCollection 2018.

17.

Circulating let-7 Levels in Serum Correlate With the Severity of Hepatic Fibrosis in Chronic Hepatitis C.

Matsuura K, Aizawa N, Enomoto H, Nishiguchi S, Toyoda H, Kumada T, Iio E, Ito K, Ogawa S, Isogawa M, Alter HJ, Tanaka Y.

Open Forum Infect Dis. 2018 Oct 22;5(11):ofy268. doi: 10.1093/ofid/ofy268. eCollection 2018 Nov.

18.

Accumulation of 9- and 13-KODEs in response to jasmonic acid treatment and pathogenic infection in rice.

Nishiguchi S, Murata K, Ube N, Ueno K, Tebayashi SI, Teraishi M, Okumoto Y, Mori N, Ishihara A.

J Pestic Sci. 2018 Aug 20;43(3):191-197. doi: 10.1584/jpestics.D18-022.

19.

Proposed model for the prediction of intrahepatic covalently closed circular DNA level in patients with chronic hepatitis B.

Hasegawa K, Nishikawa H, Enomoto H, Iwata Y, Sakai Y, Ikeda N, Takashima T, Aizawa N, Takata R, Yoh K, Ishii N, Yuri Y, Nishimura T, Iijima H, Hatano E, Fujimoto J, Nishiguchi S.

Hepatol Res. 2019 Mar;49(3):271-283. doi: 10.1111/hepr.13280. Epub 2018 Nov 26.

PMID:
30358027
20.

Analysis of opossum kidney NaPi-IIc sodium-dependent phosphate transporter to understand Pi handling in human kidney.

Fujii T, Shiozaki Y, Segawa H, Nishiguchi S, Hanazaki A, Noguchi M, Kirino R, Sasaki S, Tanifuji K, Koike M, Yokoyama M, Arima Y, Kaneko I, Tatsumi S, Ito M, Miyamoto KI.

Clin Exp Nephrol. 2019 Mar;23(3):313-324. doi: 10.1007/s10157-018-1653-4. Epub 2018 Oct 13.

PMID:
30317447
21.

Portal hypertension, oesophageal varices and caput medusae.

Nagasaki S, Nishiguchi S, Branch J.

QJM. 2019 Mar 1;112(3):231. doi: 10.1093/qjmed/hcy226. No abstract available.

PMID:
30295853
22.

Efficacy and safety of sofosbuvir-velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial.

Takehara T, Sakamoto N, Nishiguchi S, Ikeda F, Tatsumi T, Ueno Y, Yatsuhashi H, Takikawa Y, Kanda T, Sakamoto M, Tamori A, Mita E, Chayama K, Zhang G, De-Oertel S, Dvory-Sobol H, Matsuda T, Stamm LM, Brainard DM, Tanaka Y, Kurosaki M.

J Gastroenterol. 2019 Jan;54(1):87-95. doi: 10.1007/s00535-018-1503-x. Epub 2018 Sep 10.

23.

The Relationship between Controlling Nutritional (CONUT) Score and Clinical Markers among Adults with Hepatitis C Virus Related Liver Cirrhosis.

Nishikawa H, Yoh K, Enomoto H, Ishii N, Iwata Y, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Hasegawa K, Takashima T, Iijima H, Nishiguchi S.

Nutrients. 2018 Aug 29;10(9). pii: E1185. doi: 10.3390/nu10091185.

24.

Extracellular Water to Total Body Water Ratio in Viral Liver Diseases: A Study Using Bioimpedance Analysis.

Nishikawa H, Yoh K, Enomoto H, Ishii N, Iwata Y, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Hasegawa K, Takashima T, Iijima H, Nishiguchi S.

Nutrients. 2018 Aug 12;10(8). pii: E1072. doi: 10.3390/nu10081072.

25.

Amplification of bacterial genomic DNA from all ascitic fluids with a highly sensitive polymerase chain reaction.

Enomoto H, Inoue SI, Matsuhisa A, Iwata Y, Aizawa N, Sakai Y, Takata R, Ikeda N, Hasegawa K, Nakano C, Nishimura T, Yoh K, Miyamoto Y, Ishii N, Yuri Y, Ishii A, Takashima T, Nishikawa H, Iijima H, Nishiguchi S.

Mol Med Rep. 2018 Aug;18(2):2117-2123. doi: 10.3892/mmr.2018.9159. Epub 2018 Jun 14.

26.

Continuous recordings of the coral bleaching process on Sesoko Island, Okinawa, Japan, over about 50 days using an underwater camera equipped with a lens wiper.

Nishiguchi S, Wada N, Yamashiro H, Ishibashi H, Takeuchi I.

Mar Pollut Bull. 2018 Jun;131(Pt A):422-427. doi: 10.1016/j.marpolbul.2018.04.020. Epub 2018 Apr 25.

PMID:
29886967
27.

Delayed isolation of smear-positive pulmonary tuberculosis patients in a Japanese acute care hospital.

Nishiguchi S, Tomiyama S, Kitagawa I, Tokuda Y.

BMC Pulm Med. 2018 May 31;18(1):94. doi: 10.1186/s12890-018-0653-1.

28.

[Sarcopenia in liver disease].

Nishiguchi S, Nishikawa H, Enomoto H.

Nihon Shokakibyo Gakkai Zasshi. 2018;115(5):415-423. doi: 10.11405/nisshoshi.115.415. Japanese. No abstract available.

PMID:
29743449
29.

The Prevalence and Implication of Zinc Deficiency in Patients With Chronic Liver Disease.

Katayama K, Kawaguchi T, Shiraishi K, Ito T, Suzuki K, Koreeda C, Ohtake T, Iwasa M, Tokumoto Y, Endo R, Kawamura N, Shiraki M, Hanai T, Habu D, Tsuruta S, Sakai H, Miwa Y, Kawada N, Kato A, Takei Y, Mine T, Kohgo Y, Seki T, Sata M, Ito Y, Fukui K, Nishiguchi S, Moriwaki H, Suzuki K.

J Clin Med Res. 2018 May;10(5):437-444. doi: 10.14740/jocmr3374w. Epub 2018 Mar 16.

30.

Pituitary apoplexy with a binasal visual field defect.

Kawahigashi T, Nishiguchi S.

QJM. 2018 Sep 1;111(9):657-658. doi: 10.1093/qjmed/hcy051. No abstract available.

PMID:
29534208
31.

Implication of exercise interventions on sleep disturbance in patients with pancreatic cancer: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Ishii N, Iwata Y, Ishii A, Yuri Y, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Feb 16;5(1):e000196. doi: 10.1136/bmjgast-2017-000196. eCollection 2018.

32.

Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Ishii N, Iwata Y, Ishii A, Yuri Y, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Feb 7;5(1):e000194. doi: 10.1136/bmjgast-2017-000194. eCollection 2018.

33.

Clinical impact of physical exercise on sleep disorder as assessed by actigram in patients with chronic pancreatitis: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Feb 14;5(1):e000193. doi: 10.1136/bmjgast-2017-000193. eCollection 2018.

34.

Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response.

Kobayashi N, Iijima H, Tada T, Kumada T, Yoshida M, Aoki T, Nishimura T, Nakano C, Takata R, Yoh K, Ishii A, Takashima T, Sakai Y, Aizawa N, Nishikawa H, Ikeda N, Iwata Y, Enomoto H, Hirota S, Fujimoto J, Nishiguchi S.

Eur J Gastroenterol Hepatol. 2018 May;30(5):546-551. doi: 10.1097/MEG.0000000000001106.

PMID:
29494353
35.

Clinical influence of exercise therapy on sarcopenia in patients with chronic pancreatitis: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2018 Jan 4;5(1):e000190. doi: 10.1136/bmjgast-2017-000190. eCollection 2018.

36.

Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis B.

Enomoto M, Nishiguchi S, Tamori A, Kozuka R, Fujii H, Uchida-Kobayashi S, Fukunishi S, Tsuda Y, Higuchi K, Saito M, Enomoto H, Kawada N.

Hepatol Res. 2018 May;48(6):459-468. doi: 10.1111/hepr.13050. Epub 2018 Feb 12.

PMID:
29314465
37.

Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease.

Takata R, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

Medicine (Baltimore). 2017 Dec;96(48):e8761. doi: 10.1097/MD.0000000000008761.

38.

Site-Seeing: Hereditary Hemorrhagic Telangiectasia with Native-Valve Endocarditis.

Kawahigashi T, Nishiguchi S, Branch J, Hiramitsu K, Niitsu T, Kitagawa I.

Am J Med. 2018 Apr;131(4):380-383. doi: 10.1016/j.amjmed.2017.11.037. Epub 2017 Dec 18. No abstract available.

PMID:
29269227
39.

Effect of physical exercise on sarcopaenia in patients with overt hepatic encephalopathy: a study protocol for a randomised controlled trial.

Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2017 Dec 10;4(1):e000185. doi: 10.1136/bmjgast-2017-000185. eCollection 2017.

40.

Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator-blinded, active-controlled trial and a phase III, multicenter, open trial.

Suzuki K, Endo R, Takikawa Y, Moriyasu F, Aoyagi Y, Moriwaki H, Terai S, Sakaida I, Sakai Y, Nishiguchi S, Ishikawa T, Takagi H, Naganuma A, Genda T, Ichida T, Takaguchi K, Miyazawa K, Okita K.

Hepatol Res. 2018 May;48(6):411-423. doi: 10.1111/hepr.13045. Epub 2018 Jan 19.

PMID:
29235218
41.

Low incidence of hepatitis B virus reactivation and subsequent hepatitis in patients with chronic hepatitis C receiving direct-acting antiviral therapy.

Tamori A, Abiru S, Enomoto H, Kioka K, Korenaga M, Tani J, Enomoto M, Sugiyama M, Masaki T, Kawada N, Yatsuhashi H, Nishiguchi S, Mizokami M.

J Viral Hepat. 2018 May;25(5):608-611. doi: 10.1111/jvh.12840. Epub 2017 Dec 28.

PMID:
29194858
42.

Efficacy of capsule endoscopy in patients with cirrhosis for the diagnosis of upper gastrointestinal lesions and small bowel abnormalities: a study protocol for prospective interventional study.

Iwata Y, Nishikawa H, Enomoto H, Yoh K, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2017 Sep 14;4(1):e000168. doi: 10.1136/bmjgast-2017-000168. eCollection 2017.

43.

Effect of pretreatment psoas muscle mass on survival for patients with unresectable pancreatic cancer undergoing systemic chemotherapy.

Ishii N, Iwata Y, Nishikawa H, Enomoto H, Aizawa N, Ishii A, Miyamoto Y, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Yoh K, Sakai Y, Ikeda N, Takashima T, Takata R, Iijima H, Nishiguchi S.

Oncol Lett. 2017 Nov;14(5):6059-6065. doi: 10.3892/ol.2017.6952. Epub 2017 Sep 15.

44.

Effect of nalfurafine hydrochloride in patients with chronic liver disease with refractory pruritus on sleep disorders: a study protocol for single-arm, prospective, interventional study.

Yoh K, Nishikawa H, Enomoto H, Iwata Y, Ishii A, Yuri Y, Ishii N, Miyamoto Y, Hasegawa K, Nakano C, Takata R, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Iijima H, Nishiguchi S.

BMJ Open Gastroenterol. 2017 Sep 29;4(1):e000177. doi: 10.1136/bmjgast-2017-000177. eCollection 2017.

45.

Predictors Associated with Increase in Skeletal Muscle Mass after Sustained Virological Response in Chronic Hepatitis C Treated with Direct Acting Antivirals.

Yoh K, Nishikawa H, Enomoto H, Ishii A, Iwata Y, Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Aizawa N, Sakai Y, Ikeda N, Takashima T, Takata R, Iijima H, Nishiguchi S.

Nutrients. 2017 Oct 18;9(10). pii: E1135. doi: 10.3390/nu9101135.

47.

The in vivo antitumor effects of type I-interferon against hepatocellular carcinoma: the suppression of tumor cell growth and angiogenesis.

Enomoto H, Tao L, Eguchi R, Sato A, Honda M, Kaneko S, Iwata Y, Nishikawa H, Imanishi H, Iijima H, Tsujimura T, Nishiguchi S.

Sci Rep. 2017 Sep 22;7(1):12189. doi: 10.1038/s41598-017-12414-3.

48.

Association between mild cognitive impairment and trajectory-based spatial parameters during timed up and go test using a laser range sensor.

Nishiguchi S, Yorozu A, Adachi D, Takahashi M, Aoyama T.

J Neuroeng Rehabil. 2017 Aug 8;14(1):78. doi: 10.1186/s12984-017-0289-z.

49.

Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy.

Nishikawa H, Nishijima N, Enomoto H, Sakamoto A, Nasu A, Komekado H, Nishimura T, Kita R, Kimura T, Iijima H, Nishiguchi S, Osaki Y.

Oncol Lett. 2017 Aug;14(2):1637-1647. doi: 10.3892/ol.2017.6287. Epub 2017 May 31.

50.

Implication of Psoas Muscle Index on Survival for Hepatocellular Carcinoma Undergoing Radiofrequency Ablation Therapy.

Yuri Y, Nishikawa H, Enomoto H, Ishii A, Iwata Y, Miyamoto Y, Ishii N, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Takata R, Iijima H, Nishiguchi S.

J Cancer. 2017 Jun 1;8(9):1507-1516. doi: 10.7150/jca.19175. eCollection 2017.

Supplemental Content

Loading ...
Support Center